Kunzelmann K, Tilmann M, Hansen C P, Greger R
Physiologisches Institut, Albert-Ludwigs-Universität, Freiburg, Federal Republic of Germany.
Pflugers Arch. 1991 Jun;418(5):479-90. doi: 10.1007/BF00497776.
Chloride channels that have an intermediate conductance and are outwardly rectifying were studied by the patch-clamp technique in cell-excised membrane patches from respiratory epithelial cells in primary culture (REC) of normal and cystic fibrosis tissue, HT29 and T84 human colon carcinoma cells and placenta trophoblast cells (PTC). Chloride channels were immediately activated by the exposure of the cytosolic side of the patch to a Ringer-type solution, which lacked cytosolic components normally inhibiting chloride channels in the "on" cell configuration. Tentatively, we labelled the cytosolic component (or components) responsible for this inhibition cytosolic inhibitor (CI). The presence of CI in cytosol derived from HT29 cells was shown by assaying crude cytosol extracts from these cells on Cl- channels from HT29 cells (n = 2) and REC from normal subjects and cystic fibrosis patients (n = 4). In order to examine CI further, PTC were used as a source of cytosol. The cytosol of PTC inhibited HT29 Cl- channels in a dose-dependent manner with a half-maximal inhibition observed at a 1:6 dilution (n = 11) of the native cytosol. CI from PTC was heat-stable (10 min at 100 degrees C, n = 8). When cytosol extract was partitioned into a chloroform phase, Cl- channel inhibition was shown for the lipophilic extract (n = 12) as well as for the aqueous phase (n = 10). The inhibitory potency of the lipid extract was slightly larger than that of the aqueous phase. Several separation procedures were used to determine the molecular size of CI. When CI was filtered through 30-kDa filters at 6000 rpm for 45 min, inhibitory potency was observed in the filtrate and the retained fraction (n = 3). The same was observed with 10-kDa filters (n = 6). When CI was dialysed through a 12-kDa membrane, inhibitory capacity was recovered from the dialysate. Similarly, gel filtration indicated that CI was less than 5 kDa (n = 13) and probably less than 1.5 kDa (n = 11), but greater than 700 kDa (n = 9). CI was exposed to bead-coupled hydrolysing enzymes (trypsin, non-specific protease, lipase, alpha-amylase, nucleotidase), but none of the enzymes used destroyed the inhibitory potency of CI. These data indicate that CI is present in HT29 as well as in PTC. It inhibits reversibly intermediate-conductance outwardly rectifying Cl- channels in REC, HT29, and PTC.(ABSTRACT TRUNCATED AT 400 WORDS)
采用膜片钳技术,在来自正常组织和囊性纤维化组织的原代培养呼吸上皮细胞(REC)、HT29和T84人结肠癌细胞以及胎盘滋养层细胞(PTC)的细胞游离膜片中,研究了具有中等电导且向外整流的氯离子通道。当膜片的胞质侧暴露于一种林格氏液型溶液时,氯离子通道立即被激活,该溶液缺乏通常在“开启”细胞构型中抑制氯离子通道的胞质成分。我们初步将负责这种抑制作用的胞质成分标记为胞质抑制剂(CI)。通过检测来自HT29细胞(n = 2)以及正常受试者和囊性纤维化患者的REC(n = 4)的粗胞质提取物对HT29细胞氯离子通道的作用,证实了HT29细胞胞质中存在CI。为了进一步研究CI,将PTC用作胞质来源。PTC的胞质以剂量依赖方式抑制HT29氯离子通道,在天然胞质1:6稀释时观察到半数最大抑制(n = 11)。来自PTC的CI对热稳定(100℃ 10分钟,n = 8)。当胞质提取物分配到氯仿相时,亲脂性提取物(n = 12)以及水相(n = 10)均显示出氯离子通道抑制作用。脂质提取物的抑制效力略大于水相。采用了几种分离程序来确定CI的分子大小。当CI以6000转/分钟通过30 kDa滤器过滤45分钟时,滤液和保留部分均观察到抑制效力(n = 3)。使用10 kDa滤器时也观察到同样情况(n = 6)。当CI通过12 kDa膜透析时,透析液中恢复了抑制能力。同样,凝胶过滤表明CI小于5 kDa(n = 13),可能小于1.5 kDa(n = 11),但大于700 kDa(n = 9)。CI与珠偶联水解酶(胰蛋白酶、非特异性蛋白酶、脂肪酶、α -淀粉酶、核苷酸酶)接触,但所用的这些酶均未破坏CI的抑制效力。这些数据表明CI存在于HT29以及PTC中。它可逆地抑制REC、HT29和PTC中具有中等电导且向外整流的氯离子通道。(摘要截短于400字)